Since the control group, consisted exclusively of smokers, we performed a second analysis with ever smokers from each disease group and observed that PADI4 levels remained significantly higher in RA-ILD and IPF compared to controls (Kruskal-Wallis test, p = 0.005) (Table 2). This evidence concerns the gene PADI4 and interstitial lung disease.